Abstract
The processes of absorption, distribution and elimination are vitally important in all drug therapy, for collectively they determine the drug concentrations present at the sites of toxic and therapeutic effects. Pharmacokinetic considerations are especially critical for drugs with low therapeutic ratios, e.g. antineoplastic agents. The pharmacokinetics of nitroimidazole radiosensitizers have been reviewed recently (1). Considerable evidence now shows that all aspects of the pharmacokinetics of nitroimidazoles (as for other drugs) are strongly influenced by lipophilicity. The aim in this paper is to discuss the pharmacokinetics of nitroimidazole drugs with particular emphasis on this important property.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
P. Workman, Cancer Clin. Trials (in press) (1980).
C. Hansen, and W. J. Dunn, J. Pharm. Sci. 61:1 (1972).
J. M. Brown, and P. Workman, Radiat. Res. 82:171 (1980).
G. E. Adams, I. R. Flockhart, C. E. Smithen, I. J. Stratford, P. Wardman, and M. E. Watts, Radiat. Res. 67:9 (1976).
G. E. Adams, I. R. Flockhart, R. S. Jacobs, D. S. Sehmi, I. J. Stratford, P. Wardman, and M. E. Watts, Int. J. Radiat. Biol. 35:133 (1979).
S. I. Rapoport, in: “Blood-Brain Barrier in Physiology and Medicine” Raven, New York (1976).
R. G. Blasberg (in press).
P. Wardman, in: “Radiosensitizers of Hypoxic Cells”, A. Breccia, C. Rimondi, and G. E. Adams, eds., Elsevier, Amsterdam (1979).
R. Harrison and G. G. Lunt, in: “Biological Membranes”, Blackie, Glasgow (1975).
S. J. Singer, and G. L. Nicolson, Science 175:720 (1972).
B. B. Brodie, in: “Absorption and Distribution of Drugs”, T. B. Binns ed., Livingstone, Edinburgh (1964) pp 16–48.
M. Muller, D. G. Lindmark, and J. McLaughlin, in: “Metronidazole”, S. M. Finegold ed., Excerpta Medica, Amsterdam (1977) pp 12–19.
R. S. Weinstein, and N. S. McNutt, New Engl. J. Med., 286:521 (1972).
M. G. Farquhar, and G. E. Palade, J. Cell Biol. 17:375 (1963).
G. L. Lukas, S. D. Brindle, and P. Greengard, J. Pharm. Exp. Ther. 178:562 (1971).
R. A. S. White, P. Workman, L. N. Owen, and N. M. Bleehen, Br. J. Cancer 40:284 (1979).
R. A. S. White, and P. Workman, Br. J. Cancer 41:268 (1980).
R. A. S. White, P. Workman, and J. M. Brown, Radiat. Res. (in press) (1980).
P. Workman, unpublished (1980).
P. Wardman, E. D. Clarke, J. A. Dale, R. S. Jacobs, A. Minchinton, M. Stratford, M. E. Watts, M. Woodcock, M. Moazzam, J. Parrick, R. G. Wallace, C. E. Smithen, and D. Brown, Cancer Clin. Trials, (in press)(1980).
J. M. Brown, and W. W. Lee, Cancer Clin» Trials (in press) (1980).
I. R. Flockhart, P. W. Sheldon, I. J. Stratford, and M. E. Watts Int. J. Radiat. Biol. 34:91 (1978).
P. Workman, Br. J. Cancer 40:335 (1979).
P. Workman, Cancer Chemother. Pharmacol, (in press)(1980).
R. M. Ings, J. A. McFadzean, and W. A. Ormerod, Xenobiotica 5:223 (1975).
I. R. Flockhart, P. Large, D. Troup, S. L. Malcom, and T. R. Marten, Xenobiotica 8:97 (1978).
P. N. Giraldi, G. P. Tosolini, E. Dradi, G. Nannini, R. Longo, G. Meinardi, G. Monti, and I. De Carneri, Biochem. Pharmac. 20:339 (1971).
R. E. McMahon, J. Pharm. Sci. 55:457 (1966).
H. P. A. Illing, Biochem. Pharmac. 29:999 (1980).
D. Perrier, and D. Gibaldi, J. Pharm. Exp. Ther. 191:17 (1974).
P. Workman, N. M. Bleehen, and C. R. Wiltshire, Br. J. Cancer 41:302 (1980).
N. J. McNally, J. Denekamp, P. W. Sheldon, I. R. Flockhart and F. A. Stewart, Radiat. Res. 73:568 (1978).
J. M. Brown, and N. Y. Yu, submitted for publication (1980).
S. Dische, M. I. Saunders, I. R. Flockhart, M. E. Lee and P. Anderson, Int. J. Radiat. Oncol. Biol. Phys., 5:851 (1979).
A. J. Varghese, S. Gulyas, and J. K. Mohindra, Cancer Res. 36:3761 (1976).
Y. C. Taylor, and A. M. Rauth, Cancer Res. 38:2745 (1978).
T. H. Wasserman, T. L. Phillips, G. Van Raalte, R. Urtasun, J. Partington, D. Koziol, J. G. Schwade, D. Gangji, and J. M. Strong, Br. J. Radiol. 53:172 (1980).
P. Workman, Biochem. Pharmac. (in press) (1980).
P. Workman, J. M. Brown and S. Zamvil, in preparation.
K. R. Harrap, in: “Scientific Foundations on Oncology”, T. Symington, and R. L. Carter, eds, Heineman, London, (1976) pp 641–654.
V. A. Levin, C. S. Patlak, and H. D. Landahl, J. Pharmacokinet. Biopharm. (in press).
R. F. Anderson, and K. B. Patel, Br. J. Cancer 39:705 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Workman, P. (1982). Lipophilicity and the Pharmacokinetics of Nitroimidazoles. In: Breccia, A., Rimondi, C., Adams, G.E. (eds) Advanced Topics on Radiosensitizers of Hypoxic Cells. NATO Advanced Study Institutes Series, vol 43. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0399-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0399-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0401-3
Online ISBN: 978-1-4757-0399-3
eBook Packages: Springer Book Archive